Key Takeaways
Pomerantz LLP announced an investigation into The Clorox Company (NYSE: CLX) on behalf of investors, following a stock drop of nearly 10% after the company lowered its full-year financial guidance.
"The investigation concerns whether Clorox and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices," Pomerantz LLP said in a statement on May 21. The firm has invited investors who suffered losses to contact them.
The probe was triggered by Clorox's April 30 earnings report, in which the company disclosed that its third-quarter gross margin decreased by 140 basis points to 43.2 percent. Consequently, Clorox lowered its full-year fiscal 2026 gross margin outlook, now expecting a decline of 250 to 300 basis points, a significant revision from its prior forecast. Following the announcement, Clorox shares fell $9.33, or 9.67 percent, to close at $87.11 on May 1.
The law firm's investigation introduces legal uncertainty and potential financial liabilities for Clorox, adding to the pressure on its stock. This type of legal action is common after significant stock declines, with Pomerantz also publicizing investigations into Whirlpool Corporation and Gaia, Inc. this month for similar reasons.
This decline puts the stock at its lowest level since early 2026, testing key technical support levels for investors. The outcome of this investigation and the company's ability to stabilize its margins will be critical catalysts for the stock moving forward.
This article is for informational purposes only and does not constitute investment advice.
